123 related articles for article (PubMed ID: 34859848)
1. LINC00958/miR-3174/PHF6 axis is responsible for triggering proliferation, migration and invasion of endometrial cancer.
Li QY; Shen JQ; Li JH; Dai DF; Saeed M; Li CX
Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):6853-6861. PubMed ID: 34859848
[TBL] [Abstract][Full Text] [Related]
2. LINC00958 promotes endometrial cancer cell proliferation and metastasis by regulating the miR-145-3p/TCF4 axis.
Jiang Y; Qiao Z; Jiang J; Zhang J
J Gene Med; 2021 Jul; 23(7):e3345. PubMed ID: 33885186
[TBL] [Abstract][Full Text] [Related]
3. LINC00958/miR-627 signal axis regulates the proliferation, migration, and invasion of thyroid papillary carcinoma cells by TRIM44.
Li YQ; Wang LC; Li AX; Huang W; Song Y; Wang W
Kaohsiung J Med Sci; 2022 May; 38(5):415-424. PubMed ID: 35199939
[TBL] [Abstract][Full Text] [Related]
4. LncRNA LINC00958 promotes tumor progression through miR-4306/CEMIP axis in osteosarcoma.
Zhou Y; Mu T
Eur Rev Med Pharmacol Sci; 2021 Apr; 25(8):3182-3199. PubMed ID: 33928604
[TBL] [Abstract][Full Text] [Related]
5. LncRNA NEAT1 promotes endometrial cancer cell proliferation, migration and invasion by regulating the miR-144-3p/EZH2 axis.
Wang W; Ge L; Xu XJ; Yang T; Yuan Y; Ma XL; Zhang XH
Radiol Oncol; 2019 Nov; 53(4):434-442. PubMed ID: 31747378
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA LINC00958 promotes colorectal cancer progression by enhancing the expression of LEM domain containing 1 via microRNA miR-3064-5p.
Luo Z; Hao S; Yuan J; Zhu K; Liu S; Zhang J; Yao L
Bioengineered; 2021 Dec; 12(1):8100-8115. PubMed ID: 34672237
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA LINC00958 promotes the oral squamous cell carcinoma by sponging miR-185-5p/YWHAZ.
Wang Z; Zhu X; Dong P; Cai J
Life Sci; 2020 Feb; 242():116782. PubMed ID: 31442551
[TBL] [Abstract][Full Text] [Related]
8. LINC00958 Targets miR-145-3p/CDK1 Axis to Aggravate the Malignancy of Colon Cancer.
Zhou L; Mu D; Chen Y
Ann Clin Lab Sci; 2022 Sep; 52(5):695-706. PubMed ID: 36261176
[TBL] [Abstract][Full Text] [Related]
9. LncRNA H19 regulates the expression of its target gene HOXA10 in endometrial carcinoma through competing with miR-612.
Zhang L; Wang DL; Yu P
Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4820-4827. PubMed ID: 30070313
[TBL] [Abstract][Full Text] [Related]
10. MiR-18a-5p Promotes Proliferation, Migration, and Invasion of Endometrial Cancer Cells by Targeting THBD.
Dong H; Li Y; Zhou J; Song J
Crit Rev Eukaryot Gene Expr; 2021; 31(2):63-73. PubMed ID: 34347980
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA HOTAIR mediates the estrogen-induced metastasis of endometrial cancer cells via the miR-646/NPM1 axis.
Zhou YX; Wang C; Mao LW; Wang YL; Xia LQ; Zhao W; Shen J; Chen J
Am J Physiol Cell Physiol; 2018 Jun; 314(6):C690-C701. PubMed ID: 29466670
[TBL] [Abstract][Full Text] [Related]
12. miR-544a Stimulates endometrial carcinoma growth via targeted inhibition of reversion-inducing cysteine-rich protein with Kazal motifs.
Zheng WP; Meng FL; Wang LY
Mol Cell Probes; 2020 Oct; 53():101572. PubMed ID: 32525042
[TBL] [Abstract][Full Text] [Related]
13. CircPRKCI regulates proliferation, migration and cycle of lung adenocarcinoma cells by targeting miR-219a-5p-regulated CAMK1D.
Sui MH; Zhang WW; Geng DM; Sun DJ
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(4):1899-1909. PubMed ID: 33660800
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA VPS9D1-AS1 enhances proliferation, invasion, and epithelial-mesenchymal transition in endometrial cancer via miR-377-3p/SGK1.
Peng TF; Zhou YJ; Zhou J; Zhou Y; Li XC; Ouyang Q
Kaohsiung J Med Sci; 2022 Nov; 38(11):1048-1059. PubMed ID: 36245426
[TBL] [Abstract][Full Text] [Related]
15. MiR-29a-5p inhibits proliferation and invasion and induces apoptosis in endometrial carcinoma via targeting TPX2.
Jiang T; Sui D; You D; Yao S; Zhang L; Wang Y; Zhao J; Zhang Y
Cell Cycle; 2018; 17(10):1268-1278. PubMed ID: 29888640
[TBL] [Abstract][Full Text] [Related]
16. Circ_0039569 contributes to the paclitaxel resistance of endometrial cancer via targeting miR-1271-5p/PHF6 pathway.
Li J; Zhang Z; Hu Y; Wei Q; Shao X
Anticancer Drugs; 2022 Oct; 33(9):883-892. PubMed ID: 36136988
[TBL] [Abstract][Full Text] [Related]
17. Silencing of long noncoding RNA LINC00958 prevents tumor initiation of pancreatic cancer by acting as a sponge of microRNA-330-5p to down-regulate PAX8.
Chen S; Chen JZ; Zhang JQ; Chen HX; Qiu FN; Yan ML; Tian YF; Peng CH; Shen BY; Chen YL; Wang YD
Cancer Lett; 2019 Apr; 446():49-61. PubMed ID: 30639194
[TBL] [Abstract][Full Text] [Related]
18. Silencing of long non-coding RNA LINC00958 inhibits head and neck squamous cell carcinoma progression and AKT/mTOR signaling pathway by targeting miR-106a-5p.
Yang YF; Feng L; Shi Q; Wang LW; Hou LZ; Wang R; Fang JG
Eur Rev Med Pharmacol Sci; 2020 Aug; 24(16):8408-8417. PubMed ID: 32894548
[TBL] [Abstract][Full Text] [Related]
19. MiR-1271 inhibits cell proliferation and metastasis by targeting LDHA in endometrial cancer.
Tian Y; Chen YY; Han AL
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5648-5656. PubMed ID: 31298316
[TBL] [Abstract][Full Text] [Related]
20. LINC01410/miR-23c/CHD7 functions as a ceRNA network to affect the prognosis of patients with endometrial cancer and strengthen the malignant properties of endometrial cancer cells.
Lu M; Ding N; Zhuang S; Li Y
Mol Cell Biochem; 2020 Jun; 469(1-2):9-19. PubMed ID: 32314193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
